WuXi Biologics (Cayman) Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
7/10
|
22.32 | -27.96 | -179.82% | 116.21 | -80.79% |
| P/S |
|
4.01 | 54.94 | -92.7% |
|
|
| P/BV |
|
1.55 | 3.05 | -49.22% |
|
|
| P/FCF |
|
99.47 | 15.64 | 536.1% |
|
|
| Ev/Ebitda |
|
11.1 | 29.1 | -61.86% |
|
|
| Ev/S |
|
3.82 | -0.5185 | -836.77% |
|
|
| Ev/FCF |
|
55.38 | -6.42 | -962.76% |
|
|
| E/P |
|
0.0262 | 0.0191 | 37.07% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
9/10
|
34.43 | -262.37 | -113.12% | 36.22 | -4.93% |
| ROE |
|
7.55 | -5.11 | -247.94% |
|
|
| ROA |
|
5.46 | 0.2787 | 1860.03% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
17.97 | -266.12 | -106.75% |
|
|
| ROCE |
|
10.31 | 0.7483 | 1277.74% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
9/10
|
0.8182 | 0.5857 | 39.7% | 0.8344 | -1.94% |
| Nеt Debt/Ebitda |
|
-0.5522 | -1.06 | -48.06% |
|
|
| Debt/Ratio |
|
0.0868 | 0.1351 | -35.79% |
|
|
| Debt/Equity |
|
0.2528 | 0.8602 | -70.61% |
|
|
| Debt/Net Income |
|
1.57 | 2.28 | -31.13% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 2.92 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 1.46 | -100% | ||
| DSI |
|
0 | 0.564 | -100% |
|
|
| Average dividend growth |
|
0 | 2.92 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 3.02 | -100% |
|
|
| Average percentage for payments |
|
40.57 | 34.24 | 18.48% |
|
|
| Difference from average difference in sector |
|
-2.92 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
232.75 | 13.37 | 1640.84% | ||
| Growth impulse Ebitda in 5 years |
|
211.4 | -25.45 | -930.65% | ||
| Growth impulse Net Income in 5 years |
|
98.72 | 23.73 | 316.01% | ||
| Growth impulse FCF in 5 years |
|
-131.08 | 144.65 | -190.62% | ||
| Growth impulse EPS in 5 years |
|
61.57 | -78.86 | -178.08% |
IP Score
5.5/10
